Circulating immune complexes involving autoantibodies in chronic active hepatitis

Area of Science:

• Hepatology
• Immunology
• Autoimmunity

Background:

• Circulating immune complexes are frequently observed in inflammatory liver diseases.
• Their role and characteristics in HBsAg-negative chronic active hepatitis require further elucidation.

Purpose of the Study:

• To determine the presence, size, and autoantibody specificity of immune complexes in HBsAg-negative chronic active hepatitis.
• To assess the impact of prednisone therapy on immune complex levels and characteristics.

Main Methods:

• Sucrose density gradient ultracentrifugation was used to isolate and characterize immune complexes.
• Patients with HBsAg-negative chronic active hepatitis and systemic lupus erythematosus (SLE) were studied.
• Immune complexes were analyzed for IgG reactivity and specificity against nuclear, smooth muscle, and liver membrane antigens.

Main Results:

• Four out of six patients with chronic active hepatitis exhibited abnormal zonal profiles, indicating the presence of high molecular weight immune complexes.
• These complexes contained IgG reactive against nuclear, smooth muscle, and liver membrane antigens.
• Two patients treated with prednisone showed decreased immune complex levels and size, alongside clinical and biochemical improvement. SLE patients had normal serum gammaglobulin levels.

Conclusions:

• Immune complexes containing autoantibodies are present in HBsAg-negative chronic active hepatitis.
• These complexes may reflect a dysregulated immune clearance process in liver disease.
• Therapeutic interventions like prednisone can modulate immune complex levels and correlate with disease improvement.